Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Linagliptin Impurity | Linagliptin Impurity, is a new potent DPP-4 inhibitors structurally derived form the xanthine scaffold for the treatment of type 2 diabetes. Synonyms: (R)-7-(But-2-yn-1-yl)-3-methyl-8-(3-(((4-methylquinazolin-2-yl)methyl)amino)piperidin-1-yl)-1H-purine-2,6(3H,7H)-dione. Grades: > 95%. Molecular formula: C25H28N8O2. Mole weight: 472.54. |  |
| Linagliptin Impurity 10 (S-Isomer) | a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: (S)-Linagliptin; 8-[(3S)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione. Grades: > 95%. CAS No. 668270-11-9. Molecular formula: C25H28N8O2. Mole weight: 472.55. | |
| Linagliptin Impurity 11 | Grades: > 95%. Molecular formula: C25H28N8O2. Mole weight: 472.55. | |
| Linagliptin Impurity 12 | Grades: > 95%. Molecular formula: C31H38N8O7. Mole weight: 634.70. | |
| Linagliptin Impurity 13 | Grades: > 95%. Molecular formula: C20H18BrN5O4. Mole weight: 472.30. | |
| Linagliptin impurity 14 | Grades: > 95%. Molecular formula: C45H44N14O4. Mole weight: 844.94. | |
| Linagliptin impurity 16 | Grades: > 95%. Molecular formula: C20H18N6O2. Mole weight: 374.41. | |
| Linagliptin Impurity 4 | Grades: > 95%. Molecular formula: C35H36N10O2. Mole weight: 628.74. | |
| Linagliptin Impurity 6 | Grades: > 95%. Molecular formula: C50H56N16O4. Mole weight: 945.11. | |
| Linagliptin Impurity 7 | Grades: > 95%. Molecular formula: C25H29N7O4. Mole weight: 491.55. | |
| Linagliptin impurity 8 | Linagliptin impurity 8. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1398044-48-8. Molecular formula: C25H25D3N8O2. Mole weight: 475.57. Catalog: APB1398044488. |  |
| Linagliptin Impurity 8 | Grades: > 95%. Molecular formula: C26H28N8O3. Mole weight: 500.56. | |
| Linagliptin Impurity 9 | Grades: > 95%. Molecular formula: C27H33N9O2. Mole weight: 515.62. | |
| Linagliptin Impurity B | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 8-Bromo-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione; 1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-3-methyl-1,7-bis[(4-methyl-2-quinazolinyl)methyl]-; 8-Bromo-3,7-dihydro-3-methyl-1,7-bis[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione. Grades: ≥95%. CAS No. 2138392-83-1. Molecular formula: C26H21BrN8O2. Mole weight: 557.41. | |
| Linagliptin Impurity D | Synonyms: (R)-tert-butyl 1-(7-(but-2-ynyl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-ylcarbamate; tert-butyl N-[(3R)-1-(7-but-2-ynyl-3-methyl-2,6-dioxopurin-8-yl)piperidin-3-yl]carbamate; MKEXJLGKOKCUEB-CYBMUJFWSA-N; SCHEMBL638558; F19282; A899868; 3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-tert-butoxycarbonylaminopiperidin-1-yl)xanthine; 3-Methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tertbutyloxycarbonylamino)piperidin-1-yl]-xanthine; (R)-tert-butyl1-(7-(but-2-ynyl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-ylcarbamate; 3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert.-butyloxycarbonyl-amino)-piperidin-1-yl]-xanthine. Grades: > 95%. CAS No. 666816-91-7. Molecular formula: C20H18N6O3. Mole weight: 390.40. | |
| Linagliptin Impurity E | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin; (R)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione. CAS No. 1446263-38-2. Molecular formula: C25H28N8O2. Mole weight: 472.5. | |
| Linagliptin Impurity F | a useful synthetic compound. Synonyms: (R)-tert-Butyl (1-((4-Methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate; 4-[(4-Methyl-2-quinazolinyl)methyl]-1-piperazinecarboxylic Acid 1,1-Dimethylethyl Ester. Grades: > 95%. Molecular formula: C19H26N4O2. Mole weight: 342.44. | |
| Linagliptin Impurity F | Linagliptin Impurity F. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide. CAS No. 1673546-62-7. Molecular formula: C27H27F3N8O3. Mole weight: 568.55. Catalog: APB1673546627. | |
| Linagliptin Impurity I | Grades: > 95%. Molecular formula: C23H26N8O4. Mole weight: 478.51. | |
| Linagliptin Impurity II | Grades: > 95%. Molecular formula: C25H26N8O3. Mole weight: 486.54. | |
| Linagliptin Impurity KH | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Grades: ≥95%. Molecular formula: C25H29N7O4. Mole weight: 491.55. | |
| Linagliptin impurity KH-3 | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: tert-butyl (R)-(1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate; (R)-tert-Butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate. Grades: ≥95%. CAS No. 2279114-27-9. Molecular formula: C30H37N7O6. Mole weight: 591.66. | |
| Linagliptin Impurity M | Synonyms: (R)-1-BENZYL-3-N-BOC-AMINOPIPERIDINE. Grades: > 95%. CAS No. 216854-24-9. Molecular formula: C17H26N2O2. Mole weight: 290.4. | |
| Linagliptin Impurity N | Synonyms: 2-QuinazolineMethanol, 4-Methyl-; (4-Methylquinazolin-2-yl)Methanol. Grades: > 95%. CAS No. 13535-91-6. Molecular formula: C10H10N2O. Mole weight: 174.20. | |
| Linagliptin Impurity QJ | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Grades: ≥95%. Molecular formula: C25H27N7O3. Mole weight: 473.54. | |
| Linagliptin Impurity S | an impurity of Linagliptin. Synonyms: N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin (E/Z Mixture); 8-[(3R)-3-Amino-1-piperidinyl]-7-[(2E/Z)-3-bromo-2-buten-1-yl]-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione. Grades: > 95%. Molecular formula: C25H29BrN8O2. Mole weight: 553.47. | |
| Linagliptin Impurity SIM | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Grades: ≥95%. Molecular formula: C26H21BrN8O2. Mole weight: 557.41. | |
| Linagliptin Impurity SQBOC | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Grades: ≥95%. Molecular formula: C24H32N6O4. Mole weight: 468.56. | |
| Linagliptin Impurity XDBoc | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Grades: ≥95%. Molecular formula: C30H37BrN8O4. Mole weight: 653.58. | |
| Linagliptin Impurity YYJ | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 7-(But-2-yn-1-yl)-8-ethoxy-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (Linagliptin Impurity); Linagliptin Impurity YYJ. Grades: ≥95%. CAS No. 1803079-48-2. Molecular formula: C22H22N6O3. Mole weight: 418.46. | |
| Linagliptin Diene Impurity | an impurity in the synthesis of Linagliptin. Synonyms: Des-(N-butyn-1-yl) N-(Buta-1,2-Dien-1-yl) Linagliptin; 8-((R)-3-Aminopiperidin-1-yl)-7-(buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione. Grades: > 95%. Molecular formula: C25H28N8O2. Mole weight: 472.54. | |
| Linagliptin Dimer Impurity 2 | Cas No. 1418133-47-7. | |
| Linagliptin Dimer Impurity 3 | Grades: > 95%. Molecular formula: C52H60N16O4. Mole weight: 973.16. | |
| Linagliptin Dimer Impurity 5 | Grades: > 95%. Molecular formula: C60H62N18O4. Mole weight: 1099.28. | |
| Linagliptin N-Acetyl Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Synonyms: (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide. Grades: 95%. CAS No. 1803079-49-3. Molecular formula: C27H30N8O3. Mole weight: 514.58. | |
| Linagliptin N-Boc Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Synonyms: Linagliptin Related Compound B, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-carbamic Acid 1,1-Dimethylethyl Ester. Grades: 95%. CAS No. 668273-75-4. Molecular formula: C30H36N8O4. Mole weight: 572.67. | |
| Linagliptin N-Formyl Impurity | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: Linagliptin Impurity JX; (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide. Grades: ≥95%. CAS No. 2137744-33-1. Molecular formula: C26H28N8O3. Mole weight: 500.55. | |
| Linagliptin Phthalimide Impurity | Grades: > 95%. Molecular formula: C33H32N8O4. Mole weight: 604.67. | |
| 7-(But-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: Linagliptin Impurity H; 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-8-(dimethylamino)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. Grades: ≥95%. CAS No. 1646355-34-1. Molecular formula: C22H23N7O2. Mole weight: 417.46. | |
| 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine; 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione; Linagliptin Impurity A. Grades: 98%. CAS No. 853029-57-9. Molecular formula: C20H17BrN6O2. Mole weight: 453.29. | |
| Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin | Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin is an impurity of Linagliptin (L465900), a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Biochemicals. Grades: Highly Purified. CAS No. 1446263-38-2. Pack Sizes: 1mg. Molecular Formula: C25H28N8O2, Molecular Weight: 472.54. US Biological Life Sciences. |  Worldwide |
| Linagliptin Acetamide | Linagliptin Acetamide. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-N-(1-(7-(But-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide,N-[(3R)-1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]acetamide. CAS No. 1803079-49-3. Pack Sizes: 10MG. IUPAC Name: N-[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]acetamide. Molecular formula: C27H30N8O3. Mole weight: 514.58. Catalog: APS1803079493. SMILES: CC#CCn1c(nc2N(C)C(=O)N(Cc3nc(C)c4ccccc4n3)C(=O)c12)N5CCC[C@H](C5)NC(=O)C. Format: Neat. Shipping: Room Temperature. | |
| Linagliptin Acetamide-d3 | Linagliptin Acetamide-d3 is the isotope labelled analog of Linagliptin Acetamide. Linagliptin Acetamide is an impurity of linagliptin, which is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Biochemicals. Alternative Names: (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide-d3. Grades: Highly Purified. CAS No. 1297274-00-0. Pack Sizes: 1mg, 2.5mg, 5mg. Molecular Formula: C27H27D3N8O3. US Biological Life Sciences. | Worldwide |
| Linagliptin Des-Piperidine amine | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: Linagliptin J; 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. Grades: ≥95%. CAS No. 1911621-52-7. Molecular formula: C20H18N6O2. Mole weight: 374.40. | |
| Linagliptin Metabolite CD1790 | an impurity in the synthesis of Linagliptin. Synonyms: 3-Deamino 3-Hydroxy Linagliptin; (S)-7-(But-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione. Grades: > 95%. Molecular formula: C25H27N7O3. Mole weight: 473.54. | |
| Linagliptin Methyldimer | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 8-[(3R)-3-Amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione; 8-((R)-3-Aminopiperidin-1-yl)-1-((4-((2-((8-((R)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)-4-methyl-1,4-dihydroquinazolin-4-yl)methyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione; Linagliptin Dimer Impurity. Grades: > 95%. CAS No. 1418133-47-7. Molecular formula: C50H56N16O4. Mole weight: 945.08. | |
| N-(2-Acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 1H-Purine-1-acetamide, N-(2-acetylphenyl)-8-bromo-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-; Linagliptin impurity KH-2. Grades: ≥95%. CAS No. 2279114-31-5. Molecular formula: C20H18BrN5O4. Mole weight: 472.29. | |
| N-(2-acetylphenyl)-2-chloroacetamide | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: Acetamide, N-(2-acetylphenyl)-2-chloro-; Linagliptin Impurity A. Grades: ≥95%. CAS No. 6140-11-0. Molecular formula: C10H10ClNO2. Mole weight: 211.64. | |
| N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin (E/Z Mixture) | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: Bromobutane Linagliptin; (R,E)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione. Grades: ≥95%. CAS No. 1638744-06-5. Molecular formula: C25H29BrN8O2. Mole weight: 553.45. | |
| (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione; Linagliptin Impurity C. Grades: ≥95%. CAS No. 1791405-13-4. Molecular formula: C15H20N6O2. Mole weight: 316.36. | |
| tert-butyl (S)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate; Linagliptin Impurity E. CAS No. 668273-75-3. Molecular formula: C30H36N8O4. Mole weight: 572.66. | |
| Trifluoro acetyl amino Linagliptin | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroace; Linagliptin Impurity F. CAS No. 1673546-62-7. Molecular formula: C27H27F3N8O3. Mole weight: 568.55. | |
Our database is helping our users find suppliers everyday.
